ECSP982800A - METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES - Google Patents

METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

Info

Publication number
ECSP982800A
ECSP982800A ECSP982800A ECSP982800A EC SP982800 A ECSP982800 A EC SP982800A EC SP982800 A ECSP982800 A EC SP982800A EC SP982800 A ECSP982800 A EC SP982800A
Authority
EC
Ecuador
Prior art keywords
methods
proliferative diseases
treatment
elicited
conjunction
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Ashit K Ganguly
Ronald J Doll
Viyyoor Moopil Girijavallabhan
Walter Robert Bishop
David L Cutler
Joseph J Catino
Paul Kirschimeier
Ming Liu
Loretta L Nielsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982800 priority Critical patent/ECSP982800A/en
Publication of ECSP982800A publication Critical patent/ECSP982800A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se provocan métodos para tratar enfermedades proliferativas especialmente cánceres que comprenden administrar (1) un inhibidor de la transferasa de proteina farnesilo conjuntamente con (2) un agente antineoplástico y/o terapia de radiación.Methods for treating proliferative diseases especially cancers are elicited which comprise administering (1) a farnesyl protein transferase inhibitor in conjunction with (2) an antineoplastic agent and / or radiation therapy.

ECSP982800 1998-12-21 1998-12-21 METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES ECSP982800A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982800 ECSP982800A (en) 1998-12-21 1998-12-21 METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982800 ECSP982800A (en) 1998-12-21 1998-12-21 METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

Publications (1)

Publication Number Publication Date
ECSP982800A true ECSP982800A (en) 1999-05-17

Family

ID=42043717

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982800 ECSP982800A (en) 1998-12-21 1998-12-21 METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

Country Status (1)

Country Link
EC (1) ECSP982800A (en)

Similar Documents

Publication Publication Date Title
AP1599A (en) Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties.
BR0115087A (en) Radioactive limb for use in brachytherapy and methods of making a radioactive limb and treating a condition that responds to radiation therapy.
EA200100572A1 (en) METHOD OF APPLICATION OF CYCLOOXIGENASE-2 INHIBITOR AND ONE OR MULTIPLE ANTITUMOR MEDICINES AS A COMBINED METHOD OF MEDICAL EXPOSURE IN THE TREATMENT OF NEOPLASIA
MY120841A (en) Methods of inducing cancer cell death and tumor regression
FI961621A0 (en) Substituted tetra- and pentapeptide inhibitors of protein: farnesyl transferase
BRPI0207961B8 (en) use of epothilone and capecitabine analogues to manufacture medicine to treat solid cancerous tumors and kit comprising said compounds.
TR200101481T2 (en) Cancer treatment composition and method using natural herbal essential oils.
PT1157041E (en) ANTIBODIES FOR CANCER THERAPY AND DIAGNOSIS
GR3036047T3 (en) Inherited and somatic mutations of apc gene in colorectal cancer of humans.
MY119711A (en) Method of inhibiting photoaging of skin
ES2137554T3 (en) 2- (2-AMINO-3-METOXIFENIL) -4-OXO-4H- (1) BENZOPYRAN FOR THE TREATMENT OF PROLIFERANT DISORDERS.
PT954299E (en) SIGNIFICANT HORMONAL ANALOGUES FOR THE TREATMENT OF MALIGNANT TUMORS
BR9508886A (en) Compounds and methods for the treatment of cancer
MY138883A (en) Use of asiatic acid for treatment of cencer
ES2181298T3 (en) THYROXINE ANALOGS THAT HAVE A NON-SIGNIFICANT HORMONAL ACTIVITY FOR THE TREATMENT OF EVIL TUMORS.
SG144712A1 (en) Nordihydroguaiartic derivaties for use in treatment of tumors
MY137303A (en) Methods for treating proliferative diseases
AR012626A1 (en) A PHARMACEUTICAL COMPOSITION COMPRISING A DERIVATIVE OR ANALOGUE OF LEPTIN AS AN INHIBITOR OF THE PROLIFERATION OF TUMOR CELLS AND THE USE OF SUCH PHARMACEUTICAL COMPOSITION FOR THE MANUFACTURE OF MEDICINE FOR THE TREATMENT OF TUMORS
BR9808858A (en) Anti-tumor therapies comprising a combination of a cartilage extract and an antineoplastic agent providing high efficacy and low toxic side effects
BR0108728A (en) Pharmaceutical Combination Therapy, and, Method for Treating a Cancer.
BR0114430A (en) Processes for cancer cell death induction and tumor regression
ES2179204T3 (en) HYDRAZINS 2-AMINOCARBONIL-1,2-BIS (METILSULFONIL) -1-ANTITUMOR REPLACEMENTS.
PT971710E (en) USE OF QUELERITRINA AND RADIACAO FOR TUMOR THERAPY
PA8453601A1 (en) FARNESIL TRANSFERASE INHIBITORS COMBINED WITH HMG COA REDUCTASE INHIBITORS FOR CANCER TREATMENT
ECSP982800A (en) METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES